Jason Wittes
Stock Analyst at Roth MKM
(1.27)
# 2,336
Out of 4,829 analysts
62
Total ratings
41.67%
Success rate
-7.58%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $390.26 | +16.85% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.34 | +583.76% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.62 | +106.11% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.67 | +858.08% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $12.72 | +73.02% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $52.82 | +36.31% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.07 | +116.96% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $59.05 | +94.75% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $6.54 | +450.46% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $6.96 | +58.16% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.15 | +769.57% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $83.67 | +19.52% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.14 | +133.64% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.64 | +448.78% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $36.43 | +105.87% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $12.64 | +74.05% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $97.91 | +22.56% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $163.04 | +26.35% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $204.91 | -29.24% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $8.71 | +72.22% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $18.44 | +984.60% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $34.68 | -25.03% | 1 | Feb 22, 2017 |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $390.26
Upside: +16.85%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.34
Upside: +583.76%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.62
Upside: +106.11%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.67
Upside: +858.08%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $12.72
Upside: +73.02%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $52.82
Upside: +36.31%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.07
Upside: +116.96%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $59.05
Upside: +94.75%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $6.54
Upside: +450.46%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $6.96
Upside: +58.16%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $83.67
Upside: +19.52%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.14
Upside: +133.64%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.64
Upside: +448.78%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $36.43
Upside: +105.87%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $12.64
Upside: +74.05%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $97.91
Upside: +22.56%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $163.04
Upside: +26.35%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $204.91
Upside: -29.24%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $8.71
Upside: +72.22%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $18.44
Upside: +984.60%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $34.68
Upside: -25.03%